Illumina Ventures Labs, an early-stage company creation and investment engine with fully equipped genomics labs, is now operational.
Based in Foster City, CA and Cambridge, UK, the Labs is finalizing agreements with several startup companies.
Illumina Ventures Labs is part of Illumina Ventures, the genomics and precision health venture firm supporting genomics startups, from company formation to Series A financings, via access to capital, sequencing, mentorship, and fully equipped genomics lab capabilities. With its sequencing capabilities and state-of-the-art life science technologies from Illumina (NASDAQ: ILMN) and Illumina Ventures’ portfolio companies, Illumina Ventures Labs is positioned to enable early-stage companies to accelerate the time needed to reach their next value inflection point.
Illumina Ventures Labs capitalizes on Illumina Ventures’ deep technical and entrepreneurial expertise to support the development and acceleration of early-stage breakthrough genomics startups from company formation through Series A financings.
Labs-based companies will receive direct mentorship as well as connections to other companies within the Illumina Ventures portfolio, which may drive further value creation for all companies.
As part of a strategic relationship with Illumina, Inc., Labs-based companies will also gain access to subject matter experts in Illumina’s R&D organization. In order to access and fully develop scientific excellence, Illumina Ventures Labs will allow companies to stay in Labs for up to eighteen months and employ virtual and hybrid formats.